FRTX

BOULDER, Colo., Feb. 25, 2025 /PRNewswire/ -- Fresh Tracks Therapeutics, Inc. (OTC:FRTX) ("Fresh Tracks" or the "Company") announced today an update on its previously announced, planned dissolution and its process for distributing cash to its stockholders. Fresh Tracks plans on filing a Certificate of Dissolution with the Delaware Secretary of State, with dissolution effective February 28, 2025. As previously disclosed, on January 15, 2025, the Court of Chancery of the State of Delaware appointed Albert N. Marchio II as the custodian of the Company (the "Custodian"). In connection with the dissolution, the Custodian has authorized an initial distribution of $0.96 per share to holders, as of

In the news release, Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution, issued 27-Jan-2025 by Fresh Tracks Therapeutics, Inc. over PR Newswire, we are advised by the company that the reference to "...first quarter of 2024" at the end of the first paragraph was incorrectly stated and should read "...first quarter of 2025". The complete, corrected release follows: Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution BOULDER, Colo., Jan. 27, 2025 /PRNewswire/ -- Fresh Tracks Therapeutics, Inc. (OTC:FRTX) ("Fresh Tracks" or "the Company") announced today that the Court of Chancery of the State of Delaware ("the Court") has g

BOULDER, Colo., Jan. 27, 2025 /PRNewswire/ -- Fresh Tracks Therapeutics, Inc. (OTC:FRTX) ("Fresh Tracks" or "the Company") announced today that the Court of Chancery of the State of Delaware ("the Court") has granted the consent judgment agreed to by the Company in the case of David R. McAvoy versus Fresh Tracks, as a result of which the Court has appointed Albert N. Marchio II, Chief Executive Officer and Chief Financial Officer of Fresh Tracks, as the custodian of Fresh Tracks pursuant to 8 Del. C. § 226 with a directive to dissolve the Company and wind up its affairs. Fresh Tracks currently anticipates it will complete the dissolution and make a distribution of between $0.95 and $0.98 per

BOULDER, Colo., Dec. 6, 2024 /PRNewswire/ -- Fresh Tracks Therapeutics, Inc. (OTC:FRTX) ("Fresh Tracks" or "the Company") announced today that a Scheduling Order has been issued by the Court of Chancery of the State of Delaware ("the Court") setting a hearing date of January 17, 2025, for the Court to consider entry of a Consent Judgment agreed to by the Company in the case of David R. McAvoy versus Fresh Tracks. If the Consent Judgment is approved by the Court, a custodian will be appointed for Fresh Tracks pursuant to 8 Del. C. § 226 with a directive to dissolve the Company and windup its affairs. In accordance with a Court-approved scheduling order, Fresh Tracks has sent or will send to

BOULDER, Colo., June 17, 2024 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (OTC:FRTX) ("Fresh Tracks" or the "Company") announced today that it has filed an Answer (the "Answer") to a Verified Petition for Appointment of a Custodian Pursuant to 8 Del. C. § 226 (the "Delaware Petition") that was filed with the Court of Chancery of the State of Delaware (the "Court") on May 17, 2024 by a stockholder and former General Counsel, Chief Compliance Officer, and Secretary of the Company, David R. McAvoy (the "Petitioner"). The Delaware Petition, to which the Answer outlines the Company is in overall agreement with, specifically requests that the Court issue an order appointing Albert N. Ma

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

The Dow Jones index closed higher by around 575 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform. Grove Collaborative Holdings The Trade: Grove Collaborative Holdings, Inc. (NYSE:GROV) President and CEO Jeffrey Michael Yurcisin bought a total of 17,100 shares at an average price of $1.63. To acquire these shares, it cost around $27,951. Wh

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

The Dow Jones index closed lower by 0.5% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform. MultiPlan The Trade: MultiPlan Corporation (NYSE:MPLN) Director Anthony Colaluca Jr bought a total of 160,000 shares at an average price of $0.60. To acquire these shares, it cost around $96,000. What's Happening: On May 8, MultiPlan posted a GAAP loss of

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

SC 13D - Fresh Tracks Therapeutics, Inc. (0000819050) (Subject)

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

The Dow Jones index closed higher by more than 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. TSS The Trade: TSS, Inc. (OTC:TSSI) President and CEO Darryll E Dewan acquired a total of 10,000 shares an average price of $0.60. To acquire these shares, it cost around $6,000.. What’s Happening: On March 28, TSS, reported results for its

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

The Dow Jones index closed higher by over 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Vista Gold The Trade: Vista Gold Corp. (NYSE:VGZ) CFO Douglas L. Tobler acquired a total of 3,500 shares an average price of $0.48. To acquire these shares, it cost around $1,691. What’s Happening: On March 14, Vista Gold posted a fourth-quarte

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

15-12G - Fresh Tracks Therapeutics, Inc. (0000819050) (Filer)

10-K - Fresh Tracks Therapeutics, Inc. (0000819050) (Filer)

The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Rave Restaurant The Trade: Rave Restaurant Group, Inc. (NASDAQ:RAVE) CEO Brandon Solano acquired a total of 11,376 shares an average price of $1.72. To acquire these shares, it cost around $19,621. What’s Happening: On Feb. 1, RAVE Restaurant Grou

4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)